Like previous years, the early 2025 Samsung flagship phone series contains three models, the Galaxy S25, Galaxy S25 Plus, and the Galaxy S25 Ultra. The main difference between the three is size.

If you purchase a product or register for an account through a link on our site, we may receive compensation. By using this site, you consent to our User Agreement and agree that your clicks ...

If you purchase a product or register for an account through a link on our site, we may receive compensation. By using this site, you consent to our User Agreement and agree that your clicks ...

The Champions Trophy has been once shared between two teams due to rain and no result. India and Sri Lanka were declared joint winners in 2002. But what happens if the 2025 Champions Trophy final ...

Journavx costs $15.50 per 50 mg tablet, taken twice daily, making it pricier than opioids. Vertex's Q4 sales hit $2.91 billion, up 16% YoY, beating the $2.78 billion consensus. Next: Get access to ...

Vertex has stepped up its interest in kidney disease over the past year, moving inaxaplin into a phase 2/3 AMKD trial at the start of April and inking a $4.9 billion deal to buy Alpine Immune ...

Vertex Pharmaceuticals Inc. ’s new non-opioid painkiller is being placed for now on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc. ’s approved drug lists.

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

Vertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, “Journavx has been placed on Tier 3 of the Optum ...

The ESPN documentary series "The Last Dance" showed a younger generation of NBA fans that Michael Jordan is much more than a guy who sells retro sneakers. For those who witnessed Jordan's ...

In two randomized clinical trials evaluating pain control following abdominoplasty and bunionectomy, Journavx demonstrated statistically significant reductions in acute surgical pain over 48 hours ...